Published in Dig Dis Sci on August 24, 2012
Association between TLR2 and TLR4 Gene Polymorphisms and the Susceptibility to Inflammatory Bowel Disease: A Meta-Analysis. PLoS One (2015) 0.85
Toll-like receptor 4 Asp299Gly and Thr399Ile polymorphisms: New data and a meta-analysis. BMC Gastroenterol (2014) 0.81
Genetic update on inflammatory factors in ulcerative colitis: Review of the current literature. World J Gastrointest Pathophysiol (2014) 0.76
Association of TLR4 (896A/G and 1196C/T) Gene Polymorphisms with Asthma Risk: A Meta-Analysis. Med Sci Monit (2015) 0.76
Follicular fluid oocyte/cumulus-free DNA concentrations as a potential biomolecular marker of embryo quality and IVF outcome. Biomed Res Int (2014) 0.75
Recognition of commensal microflora by toll-like receptors is required for intestinal homeostasis. Cell (2004) 29.32
Development of a Crohn's disease activity index. National Cooperative Crohn's Disease Study. Gastroenterology (1976) 15.65
Toll-like receptor 4-dependent contribution of the immune system to anticancer chemotherapy and radiotherapy. Nat Med (2007) 13.90
Toward an integrated clinical, molecular and serological classification of inflammatory bowel disease: report of a Working Party of the 2005 Montreal World Congress of Gastroenterology. Can J Gastroenterol (2005) 10.16
A simple classification of Crohn's disease: report of the Working Party for the World Congresses of Gastroenterology, Vienna 1998. Inflamm Bowel Dis (2000) 6.90
Toll-like receptor-4 is required for intestinal response to epithelial injury and limiting bacterial translocation in a murine model of acute colitis. Am J Physiol Gastrointest Liver Physiol (2005) 4.28
Coated mesalazine (5-aminosalicylic acid) versus sulphasalazine in the treatment of active ulcerative colitis: a randomised trial. BMJ (1989) 4.13
Toll-like receptor signalling in the intestinal epithelium: how bacterial recognition shapes intestinal function. Nat Rev Immunol (2010) 4.07
Innate immune recognition of infected apoptotic cells directs T(H)17 cell differentiation. Nature (2009) 3.25
Cox-2 is regulated by Toll-like receptor-4 (TLR4) signaling: Role in proliferation and apoptosis in the intestine. Gastroenterology (2006) 2.78
Genome-wide association studies in type 2 diabetes. Curr Diab Rep (2009) 2.60
TLR4 polymorphisms, infectious diseases, and evolutionary pressure during migration of modern humans. Proc Natl Acad Sci U S A (2007) 2.28
Expression of Toll-like receptor 2 (TLR2), TLR4, and CD14 in biopsy samples of patients with inflammatory bowel diseases: upregulated expression of TLR2 in terminal ileum of patients with ulcerative colitis. J Histochem Cytochem (2007) 2.06
Shift towards pro-inflammatory intestinal bacteria aggravates acute murine colitis via Toll-like receptors 2 and 4. PLoS One (2007) 2.05
Polymorphisms of the lipopolysaccharide-signaling complex in inflammatory bowel disease: association of a mutation in the Toll-like receptor 4 gene with ulcerative colitis. Clin Immunol (2004) 1.89
Analysis of TLR4 polymorphic variants: new insights into TLR4/MD-2/CD14 stoichiometry, structure, and signaling. J Immunol (2006) 1.88
Exacerbation of murine ileitis by Toll-like receptor 4 mediated sensing of lipopolysaccharide from commensal Escherichia coli. Gut (2007) 1.85
Toll-like receptors in inflammatory bowel diseases: a decade later. Inflamm Bowel Dis (2010) 1.79
Functional consequences of toll-like receptor 4 polymorphisms. Mol Med (2008) 1.76
TLR2, TLR4 and TLR9 polymorphisms and Crohn's disease in a New Zealand Caucasian cohort. J Gastroenterol Hepatol (2007) 1.70
Consequence of functional Nod2 and Tlr4 mutations on gene transcription in Crohn's disease patients. J Mol Med (Berl) (2005) 1.54
The role of the Toll receptor pathway in susceptibility to inflammatory bowel diseases. Genes Immun (2007) 1.50
A novel Toll-like receptor 4 antagonist antibody ameliorates inflammation but impairs mucosal healing in murine colitis. Am J Physiol Gastrointest Liver Physiol (2009) 1.39
Toll-like receptors 4 and 5 induce distinct types of vasculitis. Circ Res (2009) 1.37
Genome-wide association studies: past, present and future. Hum Mol Genet (2008) 1.31
TLR4 signalling in the intestine in health and disease. Biochem Soc Trans (2007) 1.31
The role of Toll-like receptor 4 Asp299Gly and Thr399Ile polymorphisms and CARD15/NOD2 mutations in the susceptibility and phenotype of Crohn's disease. Inflamm Bowel Dis (2005) 1.26
Association between Toll-like receptor 4 and inflammatory bowel disease. Inflamm Bowel Dis (2005) 1.24
The role of T-regulatory cells and Toll-like receptors in the pathogenesis of human inflammatory bowel disease. Immunology (2008) 1.23
Genetic susceptibility has a more important role in pediatric-onset Crohn's disease than in adult-onset Crohn's disease. Inflamm Bowel Dis (2007) 1.20
Mutations in pattern recognition receptor genes modulate seroreactivity to microbial antigens in patients with inflammatory bowel disease. Gut (2007) 1.13
Expression of functional D299G.T399I polymorphic variant of TLR4 depends more on coexpression of MD-2 than does wild-type TLR4. J Immunol (2010) 1.10
Has toll-like receptor 4 been prematurely dismissed as an inflammatory bowel disease gene? Association study combined with meta-analysis shows strong evidence for association. Am J Gastroenterol (2007) 1.07
The Toll-like receptor 4 D299G and T399I polymorphisms are associated with Crohn's disease and ulcerative colitis: a meta-analysis. Digestion (2010) 1.07
Innate and adaptive immune responses related to IBD pathogenesis. Curr Gastroenterol Rep (2007) 1.03
Intestinal permeability and genetic determinants in patients, first-degree relatives, and controls in a high-incidence area of Crohn's disease in Southern Italy. Am J Gastroenterol (2005) 1.00
Novel genetic markers in inflammatory bowel disease. World J Gastroenterol (2007) 0.99
Clinical significance of NOD2/CARD15 and Toll-like receptor 4 gene single nucleotide polymorphisms in inflammatory bowel disease. World J Gastroenterol (2008) 0.98
The c.1-260C>T promoter variant of CD14 but not the c.896A>G (p.D299G) variant of toll-like receptor 4 (TLR4) genes is associated with inflammatory bowel disease. Digestion (2007) 0.94
TLR4 monoclonal antibody blockade suppresses dextran-sulfate-sodium-induced colitis in mice. J Gastroenterol Hepatol (2009) 0.92
Pancreatic autoantibodies are associated with reactivity to microbial antibodies, penetrating disease behavior, perianal disease, and extraintestinal manifestations, but not with NOD2/CARD15 or TLR4 genotype in a Hungarian IBD cohort. Inflamm Bowel Dis (2009) 0.92
Toll-like receptor 4 gene in IBD: further evidence for genetic heterogeneity in Europe. Gut (2005) 0.87
Novel NOD2 haplotype strengthens the association between TLR4 Asp299gly and Crohn's disease in an Australian population. Inflamm Bowel Dis (2008) 0.85
What's new in inflammatory bowel disease in 2008? World J Gastroenterol (2008) 0.82
Advances in epidemiology and diagnosis of inflammatory bowel diseases. Curr Gastroenterol Rep (2008) 0.81
Sequence-based genotyping HPV L1 DNA and RNA transcripts in clinical specimens. Pathol Res Pract (2009) 0.79
T cell-dependent and -independent IgA responses: role of TLR signalling. Immunol Invest (2010) 0.79
Impact of TLR-4 polymorphisms on circulating levels of antibodies against Helicobacter pylori. Helicobacter (2010) 0.76
Should auld acquaintance be forgot... EMBO Rep (2004) 0.75
Toll-like receptor-4 signaling: a possible candidate pathway to support tobacco smoking effects in ulcerative colitis. Am J Gastroenterol (2008) 0.75
Gastric antral vascular ectasia (watermelon stomach) in patients with ESRD. Am J Kidney Dis (2006) 1.04
Calprotectin, calgranulin C, and other members of the s100 protein family in inflammatory bowel disease. Dig Dis Sci (2011) 0.97
A review of the postulated mechanisms concerning the association of Helicobacter pylori with ischemic heart disease. Helicobacter (2007) 0.96
Large-scale population genetic analysis for hemoglobinopathies reveals different mutation spectra in central Greece compared to the rest of the country. Am J Hematol (2007) 0.95
Angiogenin, angiopoietin-1, angiopoietin-2, and endostatin serum levels in inflammatory bowel disease. Inflamm Bowel Dis (2011) 0.92
Melena: a rare complication of duodenal metastases from primary carcinoma of the lung. World J Gastroenterol (2007) 0.90
Prevalence and clinical significance of immunoglobulin A antibodies against tissue transglutaminase in patients with diverse chronic liver diseases. Clin Diagn Lab Immunol (2005) 0.88
Autoimmune hemolytic anemia and ophthalmic artery thrombosis preceding the intestinal manifestations of Crohn's disease. Inflamm Bowel Dis (2009) 0.88
The implication of adiponectin and resistin in gastrointestinal diseases. Cytokine Growth Factor Rev (2011) 0.87
Downregulation of serum epidermal growth factor in patients with inflammatory bowel disease. Is there a link with mucosal damage? Growth Factors (2010) 0.86
Moderate performance of serum S100A12, in distinguishing inflammatory bowel disease from irritable bowel syndrome. BMC Gastroenterol (2010) 0.86
Serum and follicular fluid leptin levels are correlated with human embryo quality. Reproduction (2005) 0.85
Retractile mesenteritis presenting with malabsorption syndrome. Successful treatment with oral pentoxifylline. J Gastrointestin Liver Dis (2008) 0.84
Growth hormone, insulin-like growth factor I, and leptin interaction in human cultured lutein granulosa cells steroidogenesis. Fertil Steril (2007) 0.84
Drug-induced nephrotoxicity in inflammatory bowel disease. Nephron Clin Pract (2011) 0.81
Prevalence of coeliac disease in the adult population of central Greece. Eur J Gastroenterol Hepatol (2007) 0.80
Practical approaches to effective management of intestinal radiation injury: benefit of resectional surgery. World J Gastroenterol (2011) 0.79
Low-Grade Appendiceal Mucinous Neoplasm Presenting as a Surgical Emergency: A Case Report. Case Rep Oncol (2009) 0.78
Imbalance of tissue inhibitors of metalloproteinases (TIMP) - 1 and - 4 serum levels, in patients with inflammatory bowel disease. BMC Gastroenterol (2008) 0.78
Predominantly post-transcriptional regulation of activation molecules in chronic lymphocytic leukemia: the case of transferrin receptors. Blood Cells Mol Dis (2008) 0.77
The role of nerve growth factor in the prophylaxis and treatment of diabetic foot ulcers. Int J Burns Trauma (2011) 0.77
(99m)Tc-Leucoscan in the evaluation of inflammatory bowel disease. Eur J Nucl Med Mol Imaging (2002) 0.76
Emergence of Crohn's disease in juvenile idiopathic arthritis during treatment with etanercept: a causal link or a mere coincidence? J Gastrointestin Liver Dis (2010) 0.76
Impact of TLR-4 polymorphisms on circulating levels of antibodies against Helicobacter pylori. Helicobacter (2010) 0.76
On the management of hyperglycaemia in critically ill patients undergoing surgery. J Clin Med Res (2012) 0.75
Sickle cell trait-related ischemic colitis in a patient with Sjögren's syndrome. Am J Gastroenterol (2008) 0.75
Use of albumin polymers during breast cancer surgery improves postoperative seroma outcome. Surg Technol Int (2009) 0.75
The role of hypercoagulability in ischemic colitis. Scand J Gastroenterol (2015) 0.75
Finger clubbing and erythropoietin serum levels in active IBD. Inflamm Bowel Dis (2006) 0.75
Crohn's disease associated with severe autoimmune thrombocytopenic purpura. Inflamm Bowel Dis (2006) 0.75
Progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome) with fatal outcome, after the manifestation of an ampullary adenocarcinoma. Pancreas (2010) 0.75